drugset / Trial / NCT00842205

Role of Heme Oxygenase in the Pathogenesis of Hepatocellular Injury in Chronic Hepatitis C Virus (HCV) Infection

NCT00842205

Parallel-groupOpen-labelBasic science

Summary

In the presented project, the role of heme oxygenase 1 and 2 in the procesess associated with fibroproduction in the chronic HCV infection will be studied. Heme oxygenase expression will be evaluated by the techniques of molecular genetics and immunohistochemistry, both in the liver tissue and in peripheral blood mononuclear cells. These parameters will be correlated with basic virological and clinical characteristics of the chronic HCV infection. The investigators' expected results may help in understanding the mechanisms of fibroproduction in chronic HVC infection and, therefore, contribute to explain individual differences in the development of chronic HCV infection.

Timeline

Start
2007-01
Primary completion
2009-06
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Peginterferon alfa-2a Protein / enzyme biologic 1.5 ug/kg Subcutaneous
Comparator Peginterferon alfa-2a Protein / enzyme biologic 180 ug Subcutaneous
Comparator Ribavirin Small molecule 100 mg Oral
Comparator Ribavirin Small molecule 1000 mg Oral
Comparator Ribavirin Small molecule 1200 mg Oral